FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006036696> ?p ?o ?g. }

• W3006036696 endingPage "127" @default.
• W3006036696 startingPage "119" @default.
• W3006036696 abstract "Objective: To study the outcome of patients with AL amyloidosis who were ineligible for high dose melphalan (HDM) and autologous stem cell transplantation (ASCT).Methods: A real-life retrospective observational cohort study of Dutch patients with AL amyloidosis ineligible for HDM and ASCT was performed at the University Medical Center Groningen from January 2001 until April 2017. Primary outcome measure was overall survival (OS). Secondary outcome measures were hematological response (HR), organ responses, and treatment toxicity.Results: Eighty-four patients were included. Ineligibility was due to NYHA class III/IV (n = 58), otherwise advanced disease (n = 11), advanced age (n = 14), or treatment refusal (n = 1). Early death (<3 months) rate was high (44%). Median OS improved from 4 months in period 2001–2009 (n = 36) to 8 months in period 2009–2017 (n = 48, p = .02). HR was seen in 29%, and 42% of the patients, respectively. Median OS was 36 months after induction treatment with bortezomib (n = 32) and 18 months with immunomodulatory imide drug (IMID) (n = 16), both higher than median OS (7 months) with other regimens (n = 27). Incidence of toxicity was high (51%).Conclusion: OS improved in this high-risk group over the years, especially after introduction of new treatment modalities. However, early death rate remains high, illustrating the need for more effective treatment." @default.
• W3006036696 created "2020-02-24" @default.
• W3006036696 creator A5011050853 @default.
• W3006036696 creator A5015811637 @default.
• W3006036696 creator A5021524647 @default.
• W3006036696 creator A5049116732 @default.
• W3006036696 creator A5050532707 @default.
• W3006036696 creator A5085612827 @default.
• W3006036696 date "2020-02-13" @default.
• W3006036696 modified "2023-10-17" @default.
• W3006036696 title "A real-life cohort study of immunoglobulin light-chain (AL) amyloidosis patients ineligible for autologous stem cell transplantation due to severe cardiac involvement or advanced disease" @default.
• W3006036696 cites W1567835982 @default.
• W3006036696 cites W1971828262 @default.
• W3006036696 cites W1989138882 @default.
• W3006036696 cites W2003181078 @default.
• W3006036696 cites W2008608243 @default.
• W3006036696 cites W2012680794 @default.
• W3006036696 cites W2026585322 @default.
• W3006036696 cites W2033957884 @default.
• W3006036696 cites W2039282816 @default.
• W3006036696 cites W2069180940 @default.
• W3006036696 cites W2072587452 @default.
• W3006036696 cites W2075174733 @default.
• W3006036696 cites W2076668534 @default.
• W3006036696 cites W2092074428 @default.
• W3006036696 cites W2098093182 @default.
• W3006036696 cites W2106512137 @default.
• W3006036696 cites W2144728882 @default.
• W3006036696 cites W2153091284 @default.
• W3006036696 cites W2158206316 @default.
• W3006036696 cites W2169183166 @default.
• W3006036696 cites W2169767242 @default.
• W3006036696 cites W2171033052 @default.
• W3006036696 cites W2346818737 @default.
• W3006036696 cites W2517949488 @default.
• W3006036696 cites W2601212655 @default.
• W3006036696 cites W2604395177 @default.
• W3006036696 cites W2626892226 @default.
• W3006036696 cites W2758338575 @default.
• W3006036696 cites W2782423765 @default.
• W3006036696 cites W2892107621 @default.
• W3006036696 cites W2899144895 @default.
• W3006036696 cites W2902836701 @default.
• W3006036696 cites W2917932696 @default.
• W3006036696 cites W2963392753 @default.
• W3006036696 cites W2968936600 @default.
• W3006036696 doi "https://doi.org/10.1080/13506129.2020.1714581" @default.
• W3006036696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32052655" @default.
• W3006036696 hasPublicationYear "2020" @default.
• W3006036696 type Work @default.
• W3006036696 sameAs 3006036696 @default.
• W3006036696 citedByCount "1" @default.
• W3006036696 countsByYear W30060366962021 @default.
• W3006036696 crossrefType "journal-article" @default.
• W3006036696 hasAuthorship W3006036696A5011050853 @default.
• W3006036696 hasAuthorship W3006036696A5015811637 @default.
• W3006036696 hasAuthorship W3006036696A5021524647 @default.
• W3006036696 hasAuthorship W3006036696A5049116732 @default.
• W3006036696 hasAuthorship W3006036696A5050532707 @default.
• W3006036696 hasAuthorship W3006036696A5085612827 @default.
• W3006036696 hasBestOaLocation W30060366961 @default.
• W3006036696 hasConcept C126322002 @default.
• W3006036696 hasConcept C141071460 @default.
• W3006036696 hasConcept C159654299 @default.
• W3006036696 hasConcept C203014093 @default.
• W3006036696 hasConcept C2776364478 @default.
• W3006036696 hasConcept C2777478702 @default.
• W3006036696 hasConcept C2778684742 @default.
• W3006036696 hasConcept C2779050716 @default.
• W3006036696 hasConcept C2779551797 @default.
• W3006036696 hasConcept C2779951007 @default.
• W3006036696 hasConcept C2911091166 @default.
• W3006036696 hasConcept C36394416 @default.
• W3006036696 hasConcept C71924100 @default.
• W3006036696 hasConcept C72563966 @default.
• W3006036696 hasConcept C90924648 @default.
• W3006036696 hasConceptScore W3006036696C126322002 @default.
• W3006036696 hasConceptScore W3006036696C141071460 @default.
• W3006036696 hasConceptScore W3006036696C159654299 @default.
• W3006036696 hasConceptScore W3006036696C203014093 @default.
• W3006036696 hasConceptScore W3006036696C2776364478 @default.
• W3006036696 hasConceptScore W3006036696C2777478702 @default.
• W3006036696 hasConceptScore W3006036696C2778684742 @default.
• W3006036696 hasConceptScore W3006036696C2779050716 @default.
• W3006036696 hasConceptScore W3006036696C2779551797 @default.
• W3006036696 hasConceptScore W3006036696C2779951007 @default.
• W3006036696 hasConceptScore W3006036696C2911091166 @default.
• W3006036696 hasConceptScore W3006036696C36394416 @default.
• W3006036696 hasConceptScore W3006036696C71924100 @default.
• W3006036696 hasConceptScore W3006036696C72563966 @default.
• W3006036696 hasConceptScore W3006036696C90924648 @default.
• W3006036696 hasIssue "2" @default.
• W3006036696 hasLocation W30060366961 @default.
• W3006036696 hasLocation W30060366962 @default.
• W3006036696 hasLocation W30060366963 @default.
• W3006036696 hasLocation W30060366964 @default.
• W3006036696 hasOpenAccess W3006036696 @default.
• W3006036696 hasPrimaryLocation W30060366961 @default.

• next